Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy diversity 6-25 (IGHD6-25) is a D (diversity) gene segment within the human immunoglobulin heavy chain locus. It does not encode a protein directly but contributes, through somatic recombination with V (variable) and J (joining) gene segments, to the generation of the variable region of immunoglobulin heavy chains during B cell development. The combinatorial usage of V, D, and J segments enables the generation of a vast array of antibodies capable of recognizing diverse antigens[1][2][3]. This gene segment is a germline DNA sequence element essential for the adaptive immune system but is not itself a receptor, enzyme, transporter, or typical drug target. IGHD6-25 is not a drug target, protein, or receptor but a genomic DNA segment involved in antibody gene assembly. There are no drugs, biomarkers, or mechanisms of drug action specific to this segment, nor are there known safety concerns related to it. The target is “incorrect” in the context of typical therapeutic target lists because it does not fulfill the role of a protein target amenable to therapeutic intervention. In summary, IGHD6-25 is a small DNA segment used in forming the variable region of immunoglobulin heavy chains and is not an individual protein, receptor, or druggable target[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy diversity 6-25 (IGHD6-25).